A trial of ribociclib for children and young people with neuroblastoma or a malignant rhabdoid tumour
Cancer type:
Status:
Phase:
This trial looked at a drug called ribociclib as treatment for neuroblastoma and a rare type of childhood cancer called a malignant rhabdoid tumour.
More about this trial
- neuroblastoma - a cancer which starts in nerve cells, often in the tummy (abdomen)
- malignant rhabdoid tumour (MRT) - a rare type of cancer which can start in the kidneys
- other cancers which have specific cell or genetic changes
Summary of results
- 15 had neuroblastoma
- 15 had malignant rhabdoid tumour
- 1 had a type of sarcoma called rhabdomyosarcoma
- 1 had a type of brain tumour called anaplastic meningioma
- a drop in white blood cells, red blood cells or blood clotting cells (platelets)
- feeling or being sick
- extreme tiredness (fatigue)
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor Andrew Pearson
Supported by
NIHR Clinical Research Network: Cancer
Novartis
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040